Aptevo Therapeutics Inc. (APVO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-149.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $3.11M | $12.29M | $4.31M | $32.42M | $23.07M | $14.66M | — |
| Cost of Revenue | — | — | — | — | — | — | $19.93M | $11.21M | — | — |
| Operating Income | -$26.31M | -$24.60M | -$28.88M | -$28.64M | -$21.40M | -$27.49M | -$40.96M | -$51.66M | -$53.95M | -$138.77M |
| Net Income | -$25.97M | -$24.13M | -$17.41M | $8.03M | -$28.46M | -$17.75M | -$40.45M | -$53.69M | $6.97M | -$112.42M |
| EPS (Diluted) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | — | — | — | — | — |
| Total Assets | $27.19M | $15.59M | $24.84M | $34.22M | $56.60M | $53.55M | $53.41M | $67.49M | $117.01M | $91.86M |
| Total Liabilities | $9.81M | $10.84M | $12.62M | $16.24M | $55.38M | $36.95M | $41.57M | $37.09M | $34.97M | $41.29M |
| Shareholders' Equity | $17.38M | $4.75M | $12.22M | $17.97M | $1.22M | $16.59M | $11.84M | $30.41M | $82.03M | $50.57M |
| Cash & Equivalents | $21.62M | $8.71M | $16.90M | $22.64M | $45.04M | $39.98M | $12.45M | $30.64M | $7.09M | $9.68M |
| Operating Cash Flow | -$25.59M | -$23.79M | -$11.73M | -$21.02M | -$21.68M | -$29.32M | -$42.38M | -$51.42M | -$41.57M | — |
| Capital Expenditures | — | — | — | $29.0K | $713.0K | $88.0K | $153.0K | $976.0K | $1.40M | $2.51M |
| Shares Outstanding | 997.8K | 4.1K | 12.0K | 6.47M | 4.90M | 4.41M | 3.23M | 22.81M | 21.61M | 20.27M |